Year: 2008
Type: review
Abstract: Although amyloid deposition was noted by Alzheimer in 1907 (1Alzheimer A. Stelzmann R.A. Schnitzlein H.N. Murtagh F.R. Clin. Anat. 1995; 8: 429-431Crossref PubMed Scopus (775) Google Scholar), it has been only 17 years since the toxicity of Aβ 2The abbreviations used are: Aβ, amyloid β-protein; AD, Alzheimer disease; APP, amyloid precursor protein; NFTs, neurofibrillary tangles; FAD, familial AD; ADDLs, Aβ-derived diffusible ligands; LTD, long-term depression; MAPK, mitogen-activated protein kinase; NMDA, N-methyl-d-aspartate; GABA, γ-aminobutyric acid. was first described (2Yankner B.A. Duffy L.K. Kirschner D.A. Science. 1990; 250: 279-282Crossref PubMed Scopus (1917) Google Scholar). The prevailing view through most of the twentieth century was that Aβ is a marker of disease progression in AD but does not play a role in the neurodegenerative process. This view changed in the 1990s with the articulation of the amyloid hypothesis, which posits that abnormal accumulation of Aβ in the brain is a direct cause of neurodegeneration and cognitive decline in AD. The hypothesis is supported by the identification of mutations in APP (3Goate A. Chartier-Harlin M.C. Mullan M. Brown J. Crawford F. Fidani L. Giuffra L. Haynes A. Irving N. James L. Mant R. Newton P. Rooke K. Roques P. Talbot C. Nature. 1991; 349: 704-706Crossref PubMed Scopus (3811) Google Scholar) and presenilins 1 and 2 (4Sherrington R. Rogaev E.I. Liang Y. Rogaeva E.A. Levesque G. Ikeda M. Chi H. Lin C. Li G. Holman K. Tsuda T. Mar L. Foncin J.-F. Bruni A.C. Montesi M.P. Nature. 1995; 375: 754-760Crossref PubMed Scopus (3599) Google Scholar, 5Levy-Lahad E. Wasco W. Poorkaj P. Romano D.M. Oshima J. Pettingell W.H. Yu C.E. Jondro P.D. Schmidt S.D. Wang K. Crowley A.C. Fu Y.-H. Guenette S.Y. Galas D. Nemens E. Science. 1995; 269: 973-977Crossref PubMed Scopus (2241) Google Scholar, 6Rogaev E.I. Sherrington R. Rogaeva E.A. Levesque G. Ikeda M. Liang Y. Chi H. Lin C. Holman K. Tsuda T. Mar L. Sorbi S. Nacmias B. Piacentini S. Amaducci L. Nature. 1995; 376: 775-778Crossref PubMed Scopus (1801) Google Scholar, 7Li J. Ma J. Potter H. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 12180-12184Crossref PubMed Scopus (50) Google Scholar) that increase Aβ generation or, more importantly, the generation of a minor 42-amino acid form (Aβ42) with an increased propensity for aggregation (8Suzuki N. Cheung T.T. Cai X.D. Odaka A. Otvos Jr., L. Eckman C. Golde T.E. Younkin S.G. Science. 1994; 264: 1336-1340Crossref PubMed Scopus (1358) Google Scholar). This review sets forth the major lines of evidence for Aβ toxicity and focuses on the interface between Aβ toxicity and molecular mechanisms of synaptic plasticity. The early studies of Blessed and co-workers (9Roth M. Tomlinson B.E. Blessed G. Nature. 1966; 209: 109-110Crossref PubMed Scopus (224) Google Scholar) suggested that plaque numbers were directly related to quantitative measures of cognitive decline in the aged population. However, subsequent studies carried out by Terry et al. (10Terry R.D. Masliah E. Salmon D.P. Butters N. DeTeresa R. Hill R. Hansen L.A. Katzman R. Ann. Neurol. 1991; 30: 572-580Crossref PubMed Scopus (3423) Google Scholar) cast doubt on the predictive value of plaque numbers, suggesting instead that NFTs and synapse loss were more reliable predictors of cognitive decline. Moreover, plaque formation is a common feature of the aging human brain that can occur in the absence of cognitive decline (11Yankner B.A. Lu T. Loerch P. Annu. Rev. Pathol. 2008; 3: 41-66Crossref PubMed Scopus (473) Google Scholar). More recently, it has been suggested that accumulation of toxic oligomers of Aβ may be more relevant than plaques to mechanisms involved in cognitive decline. Transgenic mouse models expressing APP and presenilin variants associated with FAD have provided important insights into structural, neurophysiological, and behavioral effects of Aβ accumulation in the brain (12Morrissette D.A. Parachikova A. Green K.N. LaFerla F.M. J. Biol. Chem. 2009; 284 (in press)Abstract Full Text Full Text PDF PubMed Scopus (143) Google Scholar). Multiphoton imaging studies have demonstrated disrupted neurites and decreased spine density in association with fibrillar Aβ deposits in the Tg2576 transgenic mouse model that expresses the APPsw mutation (13Knowles R.B. Wyart C. Buldyrev S.V. Cruz L. Urbanc B. Hasselmo M.E. Stanley H.E. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: 5274-5279Crossref PubMed Scopus (206) Google Scholar, 14Spires T.L. Meyer-Luehmann M. Stern E.A. McLean P.J. Skoch J. Nguyen P.T. Bacskai B.J. Hyman B.T. J. Neurosci. 2005; 25: 7278-7287Crossref PubMed Scopus (477) Google Scholar). In addition, stereologic mapping of neuronal cell density showed some degree of neuronal loss in the immediate vicinity of Aβ deposits (15Urbanc B. Cruz L. Le R. Sanders J. Ashe K.H. Duff K. Stanley H.E. Irizarry M.C. Hyman B.T. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 13990-13995Crossref PubMed Scopus (188) Google Scholar). The neuritic dystrophy observed in APP transgenic mice appears to be directly related to the fibrillar component of Aβ deposits. When the APP transgenic was placed on an apoE-deficient background, Aβ deposition still occurred, but fibrillar deposits were absent, and neuritic dystrophy was markedly reduced. When apoE3 or apoE4 was expressed, fibrillar Aβ deposits appeared with concomitant neuritic degeneration that was greater for apoE4 than for apoE3 (16Holtzman D.M. Bales K.R. Tenkova T. Fagan A.M. Parsadanian M. Sartorius L.J. Mackey B. Olney J. McKeel D. Wozniak D. Paul S.M. Proc. Natl. Acad. Sci. U. S. A. 2000; 97: 2892-2897Crossref PubMed Scopus (733) Google Scholar, 17Holtzman D.M. Fagan A.M. Mackey B. Tenkova T. Sartorius L. Paul S.M. Bales K. Ashe K.H. Irizarry M.C. Hyman B.T. Ann. Neurol. 2000; 47: 739-747Crossref PubMed Scopus (268) Google Scholar). However, it was unclear from these studies which came first, neuritic degeneration or deposition of fibrillar Aβ. Another study suggested that axonal dystrophy and altered axonal transport occur early in AD and may lead to amyloid deposition (18Stokin G.B. Lillo C. Falzone T.L. Brusch R.G. Rockenstein E. Mount S.L. Raman R. Davies P. Masliah E. Williams D.S. Goldstein L.S. Science. 2005; 307: 1282-1288Crossref PubMed Scopus (981) Google Scholar). The question of which comes first, amyloid or neuritic dystrophy, was recently addressed by in vivo multiphoton microscopy in an APPswe/PS1d9XYFP transgenic mouse in which the onset of plaque formation could be accurately dated. Plaque formation was followed by progressive neuritic abnormalities that appeared in direct contiguity to the plaque, establishing a causal relationship between amyloid deposition and neuritic dystrophy (19Meyer-Luehmann M. Spires-Jones T.L. Prada C. Garcia-Alloza M. de Calignon A. Rozkalne A. Koenigsknecht-Talboo J. Holtzman D.M. Bacskai B.J. Hyman B.T. Nature. 2008; 451: 720-724Crossref PubMed Scopus (818) Google Scholar). In addition, plaques could form quickly, within 24 h, suggesting that amyloid deposition is a more dynamic process than previously appreciated. Although these findings suggest that neuritic dystrophy can be induced by fibrillar Aβ deposition, it remains to be determined whether this is mediated by Aβ fibrils or by oligomeric intermediates associated with fibrils (20Chimon S. Shaibat M.A. Jones C.R. Calero D.C. Aizezi B. Ishii Y. Nat. Struct. Mol. Biol. 2007; 14: 1157-1164Crossref PubMed Scopus (464) Google Scholar). A limitation of APP transgenic mouse models is the paucity of neuronal cell death and tau-related pathology characteristic of human AD (21Games D. Adams D. Alessandrini R. Barbour R. Berthelette P. Blackwell C. Carr T. Clemens J. Donaldson T. Gillespie F. et al.Nature. 1995; 373: 523-527Crossref PubMed Scopus (2251) Google Scholar, 22Irizarry M.C. Soriano F. McNamara M. Page K.J. Schenk D. Games D. Hyman B.T. J. Neurosci. 1997; 17: 7053-7059Crossref PubMed Google Scholar). Two potential explanations have been posited: either Aβ is not sufficient to account for the neurodegenerative process in AD, or rodent models do not accurately recapitulate the aging human brain. Evidence for the latter explanation comes from the introduction of plaque-equivalent concentrations of pre-fibrillized Aβ into the brains of aging rhesus monkeys, which induced neuronal cell death, tau pathology, and microglial activation (23Geula C. Wu C.K. Saroff D. Lorenzo A. Yuan M. Yankner B.A. Nat. Med. 1998; 4: 827-831Crossref PubMed Scopus (502) Google Scholar). These toxic effects of Aβ were age-dependent in rhesus macaques but did not appear in aging rats. Thus, aging primates may be more vulnerable to Aβ toxicity than aging rodents, possibly accounting for the relative absence of AD-type pathology in APP transgenic mouse models. The importance of Aβ aggregation in the mechanism of Aβ toxicity was noted in early cell culture studies (24Pike C.J. Walencewicz A.J. Glabe C.G. Cotman C.W. Eur. J. Pharmacol. 1991; 207: 367-368Crossref PubMed Scopus (267) Google Scholar, 25Busciglio J. Lorenzo A. Yankner B.A. Neurobiol. Aging. 1992; 13: 609-612Crossref PubMed Scopus (204) Google Scholar) and was supported by the finding that FAD mutations in APP increase generation of the highly aggregable Aβ42 peptide (8Suzuki N. Cheung T.T. Cai X.D. Odaka A. Otvos Jr., L. Eckman C. Golde T.E. Younkin S.G. Science. 1994; 264: 1336-1340Crossref PubMed Scopus (1358) Google Scholar). Recent studies suggest that low molecular weight oligomers are more toxic than the larger Aβ fibrils (26Roychaudhuri R. Yang M. Hoshi M.M. Teplow D.B. J. Biol. Chem. 2009; 284: 4749-4753Abstract Full Text Full Text PDF PubMed Scopus (540) Google Scholar). The toxicity of Aβ oligomers was described by Klein and co-workers (27Lambert M.P. Barlow A.K. Chromy B.A. Edwards C. Freed R. Liosatos M. Morgan T.E. Rozovsky I. Trommer B. Viola K.L. Wals P. Zhang C. Finch C.E. Krafft G.A. Klein W.L. Proc. Natl. Acad. Sci. U. S. A. 1998; 95: 6448-6453Crossref PubMed Scopus (3144) Google Scholar) in studies of small diffusible Aβ oligomers that they named ADDLs, which cause neuronal cell death in hippocampal slice cultures at nanomolar concentrations. Notably, ADDLs could inhibit hippocampal long-term potentiation, suggesting a potential role in memory impairment in AD. Evidence that Aβ oligomers could impair synaptic physiology in vivo came from experiments in which Aβ oligomers generated by APP-transfected Chinese hamster ovary cells were injected into the rat brain and impaired hippocampal long-term potentiation in vivo (28Walsh D.M. Klyubin I. Fadeeva J.V. Cullen W.K. Anwyl R. Wolfe M.S. Rowan M.J. Selkoe D.J. Nature. 2002; 416: 535-539Crossref PubMed Scopus (3721) Google Scholar). Injection of preparations enriched in Aβ dimers and trimers, but not monomers or fibrils, resulted in behavioral deficits in a food-related reinforcement learning paradigm. Rats that received multiple oligomer injections improved and did not show a deficit, suggesting that oligomers transiently impaired synaptic physiology but did not induce neurodegeneration. Whether the low molecular mass dimers and trimers were active or aggregated further to higher molecular mass forms into the brain was not Another study showed that a a Aβ with memory impairment in Tg2576 transgenic mice S. L. R. Glabe C.G. Yang A. M. Ashe K.H. Nature. PubMed Scopus Google Scholar). This to by the was from the transgenic mouse and injected into the rat in deficits in memory In aged transgenic cognitive deficits did not with the to suggest that may to early cognitive deficits to that occur in with cognitive impairment S. L. R. Glabe C.G. Yang A. M. Ashe K.H. Nature. PubMed Scopus Google Scholar). Moreover, in APP transgenic mice the which neuritic plaque formation but behavioral deficits more than plaque K. J. H. N. J. S. Ashe K.H. P.J. L. J. Biol. Chem. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). evidence that Aβ oligomers can with synaptic physiology and to cognitive deficits in APP transgenic it remains to be determined whether Aβ oligomers to cognitive decline in AD. The of Aβ oligomer is in and in AD Y. L. Viola K.L. M.P. Finch C.E. Krafft G.A. Klein W.L. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, L. Klein W.L. Proc. Natl. Acad. Sci. U. S. A. 2005; PubMed Scopus Google Scholar). However, a Aβ oligomer to cognitive has not been remains to be determined whether oligomers are related to of AD, NFTs, microglial synapse and neuronal cell The role of Aβ in synaptic has a of in the of AD. APP transgenic mouse models have provided evidence that synaptic can to deficits in learning and memory Jones D. Irizarry M. Younkin L. M.A. Hyman B.T. Younkin S.G. Nat. Neurosci. 1999; PubMed Scopus Google Scholar, S. A. M.P. Golde T.E. R. R. M.P. Y. LaFerla F.M. Full Text Full Text PDF PubMed Scopus Google Scholar, S. Green K.N. LaFerla F.M. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar) and that these deficits can be from amyloid plaque formation T.L. Meyer-Luehmann M. Stern E.A. McLean P.J. Skoch J. Nguyen P.T. Bacskai B.J. Hyman B.T. J. Neurosci. 2005; 25: 7278-7287Crossref PubMed Scopus (477) Google Scholar, Masliah E. L. Yu G. K. D. R.A. L. Proc. Natl. Acad. Sci. U. S. A. 1999; 96: PubMed Scopus Google Scholar, L. Masliah E. Yu M. Rockenstein G. K. D. K. L. J. Neurosci. 2000; PubMed Google Scholar). evidence for direct effects of Aβ on mechanisms of synaptic came from the study of et al. F. T. H. G. D. T. S. R. Full Text Full Text PDF PubMed Scopus Google Scholar) that neuronal can induce the of APP to Aβ and that Aβ can in synaptic This and and was by of Aβ to A role for APP was supported by studies of neuronal cultures from APP mice C. T. G. B. J. J. Neurosci. PubMed Scopus Google Scholar). the of Aβ in the brain was by synaptic in vivo Bales K.R. Paul S.M. S. Holtzman D.M. 2005; Full Text Full Text PDF PubMed Scopus Google Scholar), suggesting a dynamic APP and Aβ that may synaptic Aβ can synaptic through mechanisms to the of H. J. C. T. T. S. R. Full Text Full Text PDF PubMed Scopus Google Scholar). synaptic may MAPK, to of the at the in that in H. J. C. T. T. S. R. Full Text Full Text PDF PubMed Scopus Google Scholar). of may be mediated by of Aβ to the to activation of and the enriched may induce by the Y. C.G. Paul S. T. A.C. P.J. P. Nat. Neurosci. 2005; 8: PubMed Scopus Google Scholar). Another study suggested that of Aβ dimers and trimers to hippocampal slice cultures synapse and spine numbers M. D.M. Selkoe D.J. J. Neurosci. 2007; PubMed Scopus Google Scholar). This in for and the of and the protein loss associated with low molecular weight Aβ oligomers was by of with suggesting a than that described by et al. Y. C.G. Paul S. T. A.C. P.J. P. Nat. Neurosci. 2005; 8: PubMed Scopus Google Scholar). is unclear whether this to aggregated forms of Aβ or these suggest that Aβ can multiple synaptic in synaptic and spine loss In to the effects of Aβ on synaptic in a study demonstrated in APP transgenic mice with increased J. Wang J. N. J. Yu A. S. L. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). was suggested by in the of the of the and of the and These findings are in of evidence for increased in AD C. D.M. K. K. M. J. Stern Y. 47: PubMed Scopus Google Scholar). In addition, of suggest a for the of the a that disease progression in AD. However, the observed in this APP transgenic model is to with suggesting a of Aβ on synaptic F. T. H. G. D. T. S. R. Full Text Full Text PDF PubMed Scopus Google Scholar, H. J. C. T. T. S. R. Full Text Full Text PDF PubMed Scopus Google Scholar, Y. C.G. Paul S. T. A.C. P.J. P. Nat. Neurosci. 2005; 8: PubMed Scopus Google Scholar). effects of Aβ on synaptic in the could these The APP transgenic mouse markedly 1 in hippocampal cells that with cognitive deficits Jones B. L. J. Yu J. Masliah E. L. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). is in AD and to a aging C. J. N. J. J. R. Wu C.K. J. Neurol. PubMed Scopus Google Scholar, T. Y. S.Y. Li C. I. J. Yankner B.A. Nature. PubMed Scopus Google Scholar). is a protein in that can M.P. B. C. S. 1991; Full Text PDF PubMed Scopus Google Scholar). loss of in APP transgenic mice be of impaired neuronal Moreover, imaging studies in AD suggest that impaired may lead to at an early Wang L. S. M.J. T.T. 2007; PubMed Scopus Google Scholar). of Aβ can induce to a of neuronal APP A. Yuan M. Zhang C. M. J. B. Yankner B.A. Nat. Neurosci. 2000; 3: PubMed Scopus Google Scholar). Moreover, from APP mice are to Aβ APP in the mechanism of toxicity A. Yuan M. Zhang C. M. J. B. Yankner B.A. Nat. Neurosci. 2000; 3: PubMed Scopus Google Scholar). Aβ can induce APP and at an APP the D.C. Masliah E. Ann. Neurol. PubMed Scopus Google Scholar, M.P. Lu D.C. J. PubMed Scopus Google Scholar). This APP is D.C. S. S. Nat. Med. 2000; PubMed Scopus Google Scholar) and may a A. A. and A. Neurobiol. Scholar). Evidence that APP may be directly involved in and behavioral in APP transgenic mice was suggested by a transgenic mouse model expressing APP with the and FAD mutations with an mutation at a The mutation did not Aβ generation or plaque but synapse and memory deficits S. M. S. E. N. K. D.A. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar). of APP at these by a toxic D.C. S. S. Nat. Med. 2000; PubMed Scopus Google Scholar) or by between APP and These findings into question the role of Aβ a cause of cognitive deficits in APP transgenic However, a causal role for Aβ is supported by Aβ experiments that plaque and Aβ effects on the APP D. M. P. PubMed Scopus Google Scholar, Bales K.R. R.B. C. Wu S. Wu Holtzman D.M. Paul S.M. Nat. Neurosci. 2002; PubMed Scopus Google Scholar). of Aβ with APP, either by direct or through may at this be the most NFTs are of forms of the protein a of that can tau from and axonal A is whether and tau-related are related or studies of neuronal cultures showed that aggregated forms of Aβ induce tau at the that are in AD J. Lorenzo A. J. Yankner B.A. 1995; 14: Full Text PDF PubMed Scopus Google Scholar). APP transgenic mice increased tau in neurites neuritic plaques but do not NFTs (21Games D. Adams D. Alessandrini R. Barbour R. Berthelette P. Blackwell C. Carr T. Clemens J. Donaldson T. Gillespie F. et al.Nature. 1995; 373: 523-527Crossref PubMed Scopus (2251) Google Scholar, K. F. Wu T. H. Yu L. Science. 2007; PubMed Scopus Google Scholar). formation was observed in a transgenic mouse expressing FAD variants of APP and presenilin 1 and a tau associated with deficits appeared in these mice plaques and and with Aβ S. A. M.P. Golde T.E. R. R. M.P. Y. LaFerla F.M. Full Text Full Text PDF PubMed Scopus Google Scholar). These cognitive deficits could be by of an but only in which Aβ and tau were with a mechanism Moreover, cell culture studies suggest that may be to Aβ toxicity and that Aβ toxicity is by generation of a tau M. H.N. M.P. A. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: PubMed Scopus Google Scholar, S.Y. A. J. Neurosci. 2005; 25: PubMed Scopus Google Scholar, T. G. G. M.A. J. PubMed Scopus Google Scholar). A of tau on cognitive deficits was observed in APP transgenic mice with tau mice K. F. Wu T. H. Yu L. Science. 2007; PubMed Scopus Google Scholar). memory deficits were in with of tau and by of a tau These behavioral effects in Aβ plaque or neurites and were to a of tau on These a between neurofibrillary pathology and neurodegeneration. The on Aβ is with a of mechanisms of some of which may to of the In neuronal Aβ oligomers and ADDLs can to neuronal and induce cell death through the A. E. Glabe C. J. J. Neurosci. PubMed Scopus Google Scholar). In Aβ fibrils appear to induce a more form of neuritic dystrophy and neuronal cell toxic effects of Aβ have been associated with a of the peptide C. R. D. 1994; Full Text PDF PubMed Scopus Google Scholar) and may be mediated in through for S.D. Fu J. M. H. A. T. L. M. J. A. P. Stern D. Schmidt A.M. Nature. PubMed Scopus Google Scholar). Aβ can induce through activation of and A. C.J. Walencewicz A.J. Cotman C.W. Proc. Natl. Acad. Sci. U. S. A. PubMed Scopus Google Scholar, T. H. N. Li E. J. Yankner B.A. Yuan J. Nature. 2000; PubMed Scopus Google Scholar, Brown K. J. Neurosci. 2000; PubMed Google Scholar, M.S. Li M. J. Nature. 2000; PubMed Scopus Google Scholar). and are in the AD and with Aβ42 T. K. M. H. C. M.P. Irizarry M.C. Yuan J. Hyman B.T. J. Neurol. PubMed Scopus Google Scholar). In addition, is associated with neuritic plaques and NFTs in cognitive impairment and AD S. M. D. M. A.C. J. Pathol. 2007; Full Text Full Text PDF PubMed Scopus Google Scholar). Another mechanism of toxicity may activation of cell in which has been observed in neuronal cultures and in AD F. L. S.L. Jr., R. M. M.P. Full Text Full Text PDF PubMed Scopus Google Scholar, Y. K. J. Neurosci. PubMed Google Scholar). is the that the generation of toxic Aβ in the aging studies suggest potential for E. J. A. Science. PubMed Scopus Google Scholar) and A.M. D.B. Yuan M. Yankner B.A. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). Another of by Aβ is involved in the microglial deposits are associated with activation of in AD and in APP transgenic Aβ can to A and on to an by of and J. L. Nature. PubMed Scopus Google Scholar, J. C. J. Pathol. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar, K.J. J. L.A. K. C. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). of Aβ to the through the and and of this of and K.J. J. L.A. K. C. J. Biol. Chem. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). activation in of Aβ deposits D.M. F.R. 17: Full Text Full Text PDF PubMed Scopus Google Scholar), and loss of the microglial through of in increased Aβ deposition and death in APP transgenic mice J. M. K. C. Nat. Med. 2007; 13: PubMed Scopus Google Scholar). is the relative of microglial of Aβ microglial of toxic and in AD T. L. 2002; Full Text Full Text PDF PubMed Scopus Google Scholar). Recent studies suggest that Aβ can impair synaptic through mechanisms that to cognitive decline in AD. Evidence is that Aβ oligomers can these possibly accounting for plaque is a of cognitive be to whether is a relationship between Aβ oligomers and cognitive in at of cognitive decline. A related question is whether Aβ pathology is to mechanisms of human brain aging (11Yankner B.A. Lu T. Loerch P. Annu. Rev. Pathol. 2008; 3: 41-66Crossref PubMed Scopus (473) Google Scholar) and whether mechanisms related to and altered protein are for Aβ toxicity to
Source: Journal of Biological Chemistry
Authors: Bruce A. Yankner, Tao Lu
Institution: Harvard University
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: amyloid-beta, Alzheimer's disease, amyloid hypothesis, neurotoxicity, amyloid precursor protein, presenilin, APP mutations, familial Alzheimer's disease, neurofibrillary tangles, long-term depression, MAPK signaling, NMDA receptor, GABA receptors, neurodegeneration, pathogenesis, cognitive decline, neuroinflammation
Open Access status: hybrid
Estimated APC paid: $3,430
OpenAlex ID: W2079031778
